SCHEMBL4553471

SCHEMBL4553471

Cc1nn(C)c(-n2ccc3cc(Cl)ccc32)c1/C=C/C=O.[KH]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38
NR2F2 P24468 1/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
MAPK8 P45983 5/20 0.34
MAPK9 P45984 4/20 0.34
MAPK10 P53779 3/20 0.34
MCHR1 Q99705 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
PIM1 P11309 3/20 0.31
ROCK2 O75116 1/20 0.31
PIM3 Q86V86 1/20 0.31
MAP4K4 O95819 1/20 0.31
CSF1R P07333 1/20 0.31
CLK2 P49760 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554759 0.98 SMN1; SMN2 (0.38) SMN1; SMN2MAPTNR2F2HTTCYP1A2
SCHEMBL963702 0.88 SMN1; SMN2 (0.45) SMN1; SMN2MAPTNR2F2HTTCYP1A2
SCHEMBL4553594 0.86 KDM4E (0.35) MAPTHTR2AHTR2CMEN1KMT2A
SCHEMBL4565958 0.85 ROCK1 (0.41) SMN1; SMN2MAPTHTR2CPDGFRBL3MBTL1
SCHEMBL964782 0.84 SMN1; SMN2 (0.36) SMN1; SMN2MAPTNR2F2HTTCYP1A2
SCHEMBL962500 0.84 L3MBTL1 (0.50) SMN1; SMN2MAPTNR2F2HTTMAPK8
SCHEMBL964785 0.84 SMN1; SMN2 (0.36) SMN1; SMN2MAPTNR2F2HTTCYP1A2
SCHEMBL962501 0.84 L3MBTL1 (0.50) SMN1; SMN2MAPTNR2F2HTTMAPK8
SCHEMBL4553928 0.83 CA12 (0.35) SMN1; SMN2MAPTHTTCYP1A2CYP2C9
SCHEMBL968297 0.83 SMN1; SMN2 (0.35) SMN1; SMN2MAPTNR2F2HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118066-A1 FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA Takeda Pharmaceutical Company Limited (JP) 2009-11-18 EP disclosed
WO-2008099794-A1 FUSED RING COMPOUNDS AS PARTIAL AGONISTS OF PPAR-GAMMA TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-08-21 WO disclosed